Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Adaptyv Biosystems
AddedMar 22, 2024
UpdatedJul 2, 2026
Adaptyv Biosystems

Adaptyv Biosystems

Angel

Adaptyv Biosystems: Innovating protein engineering with advanced technology.

HQ
Lausanne, canton Vaud, CH
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Adaptyv Biosystems, founded with a mission to revolutionize protein engineering, leverages cutting-edge cell-free synthetic biology and nanofluidics. The company's core vision is to accelerate the development of novel proteins for various applications, including therapeutics, diagnostics, and industrial enzymes. Their innovative platform enables rapid and precise protein design, catering to the needs of biotechnology and pharmaceutical markets.

Notable figures associated with Adaptyv Biosystems include leading experts in synthetic biology and nanotechnology. The company has attracted significant investment from prominent venture capital firms, underscoring its potential impact. Key achievements include the successful development of their proprietary protein engineering platform, which has garnered attention for its efficiency and scalability. Adaptyv Biosystems is poised to make substantial contributions to the fields of medicine and biotechnology through its groundbreaking technology.

Adaptyv Biosystems - Similar Companies

AI Proteins logo

AI Proteins

aiproteinstx.com

Profluent Bio logo

Profluent Bio

profluent.bio

Synlife logo

Synlife

synlifebio.com

Catena Biosciences logo

Catena Biosciences

Think Bioscience logo

Think Bioscience

Adaptive Biotechnologies logo

Adaptive Biotechnologies

BrickBio logo

BrickBio

brickbio.com

Cellanome logo

Cellanome

cellanome.com

Manifold Bio logo

Manifold Bio

manifold.bio

Medium Biosciences logo

Medium Biosciences

medium.bio

CasTag Biosciences logo

CasTag Biosciences

Ginkgo Bioworks logo

Ginkgo Bioworks

ginkgobioworks.com

Evozyne logo

Evozyne

evozyne.com

Theradaptive logo

Theradaptive

theradaptive.com

Nabla Bio logo

Nabla Bio

nabla.bio

Adaptyv Biosystems - Quick Facts

Who are Adaptyv Biosystems' competitors?

Companies similar to Adaptyv Biosystems include AI Proteins, Profluent Bio, Synlife and Catena Biosciences.

When was Adaptyv Biosystems founded?

Adaptyv Biosystems was founded in 2020.

Where is Adaptyv Biosystems' headquarters located?

Adaptyv Biosystems' headquarters is located in Lausanne, canton Vaud, CH.

When was Adaptyv Biosystems' last funding round?

Adaptyv Biosystems' most recent funding round was for $100k (USD) in June 2023.

How much has Adaptyv Biosystems raised to-date?

As of Jun 1, 2023, Adaptyv Biosystems has raised a total of $2.9M (USD).

How many employees does Adaptyv Biosystems have?

Adaptyv Biosystems has 7 employees as of Feb 24, 2024.

Adaptyv Biosystems - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Synthetic Biology
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Small Business
Main Product
  • Protein Engineering
Tags
  • Biotech
  • Platform
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software